- OpenEvidence
America's Official Medical Knowledge Platform OpenEvidence is the leading medical platform for healthcare professionals, featuring answers grounded in peer-reviewed research from NEJM, JAMA, NCCN, Cochrane, and more
- openevidence. org
openevidence org
- OpenEvidence - Wikipedia
OpenEvidence is an American artificial intelligence company that develops a medical search engine used by physicians for clinical decision support The company was founded in 2022 by entrepreneur Daniel Nadler and is headquartered in Miami, Florida
- OpenEvidence - Apps on Google Play
OpenEvidence is the fastest-growing and most widely-used clinical decision support platform in the world–used daily, on average, by over 40% of physicians in the United States, spanning more than
- OpenEvidence App - App Store
OpenEvidence is the fastest-growing and most widely-used clinical decision support platform in the world–used daily, on average, by over 40% of physicians in the United States, spanning more than 10,000 hospitals and medical centers nationwide
- OpenEvidence Achieves Historic Milestone: 1 Million Clinical . . .
OpenEvidence is a clinical decision support platform built to help healthcare professionals access real-time, evidence-based answers and streamline clinical workflows all within a secure,
- Mount Sinai and OpenEvidence Integrate AI Clinical Decision Support . . .
Mount Sinai Health System has initiated an enterprise-wide deployment of OpenEvidence, an AI-powered medical search and clinical decision-support platform, integrated directly into its Epic electronic health record (EHR) system The implementation represents OpenEvidence’s first large-scale rollout across a full clinical workforce, extending access beyond physicians to include registered
- Clinical Intelligence: A Strategic Analysis of OpenEvidence and the . . .
The evolution of clinical decision support systems (CDSS) has reached a critical inflection point where traditional reference models are being supplanted by agentic, multi-model architectures At the center of this transition is OpenEvidence, a platform that has ascended to a $12 Billion valuation in less than a year of public operations
|